← back to search

Scott C. Howard

University of Tennessee at Knoxville · US
Area of research
Public Health, Environmental and Occupational Health · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Medicine, Internal medicine, Pediatric oncology, Coronavirus disease 2019 (COVID-19), Psychological intervention, and Mortality rate.
h-index
citations
2,055
works
26
NIH funding
primary concept
email

Recent publications

Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospective, cohort study
The Lancet Oncology 2025cited by 17position: middledoi
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
Cancer Treatment Reviews 2023cited by 32position: middledoi
Variations of COVID-19 Mortality Are Affected by Economic Disparities Across Countries
SSRN Electronic Journal 2022cited by 2position: middledoi
Pediatric cancer care in Africa: SIOP Global Mapping Program report on economic and population indicators
Pediatric Blood & Cancer 2021cited by 36position: middledoi
COVID-19 vaccine: Call for employees in international transportation industries and international travelers as the first priority in global distribution
Open Medicine 2021cited by 5position: middledoi
From Anti-PD-1/PD-L1 to CTLA-4 and to MUC1—Is the Better Response to Treatment in Smokers of Cancer Patients Drug Specific?
Journal of Personalized Medicine 2021cited by 4position: middledoi
Smoking as a Predictor of Cell Surface Receptor Anti PD-1/PD-L1, MUC1, and CTLA-4 as the First Line or Monotherapy and Multiple Therapy Among Them in NSCLC Patients
SSRN Electronic Journal 2021cited by 0position: middledoi
Real-time estimation and prediction of mortality caused by COVID-19 with patient information based algorithm
The Science of The Total Environment 2020cited by 170position: middledoi
Setting up and sustaining blood and marrow transplant services for children in middle-income economies: an experience-driven position paper on behalf of the EBMT PDWP
Bone Marrow Transplantation 2020cited by 33position: middledoi
The Data set for Patient Information Based Algorithm to Predict Mortality Cause by COVID-19
Data in Brief 2020cited by 11position: middledoi
How to reduce the impact of cervical cancer worldwide: Gaps and priority areas identified through the essential cancer and primary care packages: An analysis of effective interventions
Cancer 2020cited by 8position: middledoi
Examining policy cohesion for cervical cancer worldwide: analysis of WHO country reports
ESMO Open 2020cited by 7position: middledoi
Smokers with PD-L1 Positive Status Benefit More than Non-Smokers in All Types of Cancer When Treated by Anti- PD-1 and PD-L1 Drugs
SSRN Electronic Journal 2020cited by 0position: middledoi
Improvement in treatment abandonment in pediatric patients with cancer in Guatemala
Pediatric Blood & Cancer 2017cited by 53position: middledoi
Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement
Pediatric Blood & Cancer 2017cited by 53position: middledoi
Recommendations for the treatment of children with radiotherapy in low‐ and middle‐income countries (LMIC): A position paper from the Pediatric Radiation Oncology Society (PROS‐LMIC) and Pediatric Oncology in Developing Countries (PODC) working groups of the International Society of Pediatric Oncology (SIOP)
Pediatric Blood & Cancer 2017cited by 32position: middledoi
Preventing and Managing Toxicities of High-Dose Methotrexate
The Oncologist 2016cited by 889position: firstdoi
Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review
Annals of Hematology 2016cited by 140position: firstdoi
Improving Care for Children With Cancer in Low- and Middle-Income Countries-A SIOP PODC Initiative
Pediatric Blood & Cancer 2015cited by 65position: middledoi
A revised definition for cure of childhood acute lymphoblastic leukemia
Leukemia 2014cited by 136position: middledoi
Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome‐positive acute lymphoblastic leukemia
Cancer 2014cited by 78position: middledoi
Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA): A model for sustainable development in pediatric oncology
Pediatric Blood & Cancer 2013cited by 94position: middledoi
Effect of body mass index on the outcome of children with acute myeloid leukemia
Cancer 2012cited by 78position: middledoi
The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi
Archives of Disease in Childhood 2012cited by 74position: lastdoi
Use of joint commission international standards to evaluate and improve pediatric oncology nursing care in Guatemala
Pediatric Blood & Cancer 2012cited by 31position: lastdoi
Stanford V chemotherapy and involved field radiotherapy for children and adolescents with unfavorable risk Hodgkin lymphoma: Results of a multi-institutional prospective clinical trial.
Journal of Clinical Oncology 2012cited by 7position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Weikuan Gu · University of Tennessee Health Science Center7 papers (2020–2022)Ching‐Hon Pui · St. Jude Children's Research Hospital5 papers (2012–2023)Lishi Wang · Guangdong University of Technology5 papers (2020–2021)Sara W. Day · University of Alabama at Birmingham5 papers (2012–2022)Jing Li · Shanxi Medical University5 papers (2020–2021)Monika L. Metzger · Médecins Sans Frontières4 papers (2012–2017)Jiafu Ji · Peking University4 papers (2020–2021)Raul C. Ribeiro · University of Colorado Denver4 papers (2012–2014)Yanhong Cao · University of Arizona4 papers (2020–2022)J. Carolyn Graff · The University of Texas Health Science Center at Houston3 papers (2020–2022)Lan Yao · Harbin Medical University3 papers (2020–2022)Helin Feng · Hebei Medical University3 papers (2020–2021)Dario Campana · National University of Singapore3 papers (2012–2014)Jeffrey E. Rubnitz · Children's Hospital3 papers (2012–2014)Hiroto Inaba · University of Tennessee at Knoxville3 papers (2012–2014)Hong Chen · The University of Texas MD Anderson Cancer Center3 papers (2020–2021)Qingyi Liu · Hebei Medical University3 papers (2020–2021)Dianjun Sun · Harbin Medical University3 papers (2020–2021)Xueyuan Cao · Amgen (United States)3 papers (2012–2020)Susana C. Raimondi · University of Alabama at Birmingham2 papers (2014–2014)